Manila Ph Feb 11 Gsk Seretide Stock Photo 1315895285 | Shutterstock
GSK seeks additional asthma indication for Trelegy Ellipta - MassDevice
GlaxoSmithKline Recalls Two Lots of Ventolin HFA Albuterol Sulfate Inhalers | Asthma and Allergy Foundation of America
Adherium wins US clearance for GSK inhaler users to connect to new platform
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy
Drugmaker GSK recalling nearly 600,000 asthma inhalers in US
GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients | Fierce Pharma
Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler ( GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
GSK Pharmaceuticals Ltd. Ventorlin Inhaler
GSK's Relvar Ellipta comes out on top in real world study
GSK opens £56m Ellipta inhaler plant in the UK
GlaxoSmithKline Recalls Ventolin Inhalers - Drug Company Announces Nationwide Recall
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy
590,000 Ventolin HFA 200D Albuterol Inhalers Recalled - Northeast Allergy, Asthma, and Immunology
Asthma Inhaler Recall: Nearly 600,000 Inhalers Affected: Advanced Allergy and Asthma: Allergists
GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media
GlaxoSmithKline Has Developed a Broad Respiratory Portfolio
GSK fails in purple inhaler passing off claim against Sandoz and Vectura (...and breathe) - The IPKat
Propeller Health to Develop Sensor for GSK Ellipta Inhaler | RT
Can Switching Inhalers Reduce Your Carbon Footprint? | MedPage Today
GSK's Arnuity and Incruse Ellipta Available in US for Asthma and COPD Patients | RT
GSK breathes freely as Mylan launches Advair generic in UK
FDA OKs Glaxo's inhaler, first one to combine 3 medicines | The Spokesman-Review
GSK Starts Phase III Study of Therapy for Patients with Asthma - Drug Discovery and Development
600,000 asthma inhalers recalled by GlaxoSmithKline - ABC7 Chicago
